Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today
Vivos Therapeutics Inc (NASDAQ:VVOS) shares are trading lower by 26.1% to $3.05 during Thursday's session after the company announced a $4.3 million registered offering of 1.36 million shares of common stock at $3.15 per share.
在週四的交易中，Vivos Therapeutics Inc (納斯達克: VVOS) 的股價下跌26.1%，至3.05美元，接近於公司宣佈以每股3.15美元的價格發行了430萬美元的註冊股票發行項目後。
The direct offering is expected to close on September 20, pending standard closing conditions, and will generate approximately $4.3 million in gross proceeds. H.C. Wainwright & Co. is the exclusive placement agent for the offering.
預計該直接發行將於9月20日結束，待滿足標準的交割條件，並將獲得約430萬美元的總收入。H.C. Wainwright資本融資公司是該發行項目的唯一放置經紀人。
Vivos says the company plans to use the net proceeds for working capital and general corporate purposes. Additionally, no stock purchase warrants are included in the offering.
Vivos表示公司計劃將淨收益用於營運資本和一般公司用途。此外，該發行項目中不包括股票購買權證。
Read Also: Bank Stocks Hit Inflection Point After Fed's 50 Basis Point Cut, Analyst Reveals Top Picks
了解更多信息：聯儲局減息50個點子後，銀行股發生拐點，分析師揭示了一些熱門選擇。
Is VVOS A Good Stock To Buy?
VVOS是一個值得購買的好股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Vivos Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定是否購買某隻股票時可以做出一些決策。除了在Benzinga的報價頁面上找到的估值指標和價格走勢以外（例如Vivos Therapeutics的頁面），還有一些因素，例如一家公司是否支付股息或每個季度購買其大部分股票。
These are known as capital allocation programs. Vivos Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本配置計劃。Vivos Therapeutics不支付股息，但顯然公司有幾種方式可以爲股東提供回報。請隨時搜索Benzinga的股息日曆，查找下一個即將支付股息的公司，並確定持有公司股份可以獲得何種收益率。
For example, if you're looking to earn an annualized return of 23.1%, you'll need to buy a share of North American Finl 15 by the Sep. 30, 2024. Once done, you can expect to receive a nominal payout of $0.11 on Oct. 10, 2024.
例如，如果您希望獲得年化回報率爲23.1%，您需要在2024年9月30日之前購買一股North American Finl 15。購買完成後，您可以預計在2024年10月10日收到0.11美元的名義支付。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Vivos Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然不同且變量很大。 一家公司可以批准回購計劃，並根據其認爲適當的時間購買股份，在授權的時間段內。通過查看最新的vivos therapeutics資訊，通常可以得知該公司最近是否批准了回購計劃。回購計劃通常用作支撐股價，充當需求的保障。
According to data from Benzinga Pro, VVOS has a 52-week high of $48.79 and a 52-week low of $1.91.
根據Benzinga Pro的數據，VVOS的52周最高價爲48.79美元，52周最低價爲1.91美元。
譯文內容由第三人軟體翻譯。